Overall survival in patients with relapsed/refractory high grade B-cell lymphomas treated with gemcitabine, oxaliplatin with or without rituximab

Leuk Lymphoma. 2019 Dec;60(13):3324-3326. doi: 10.1080/10428194.2018.1519813. Epub 2018 Oct 15.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Deoxycytidine / analogs & derivatives
  • Gemcitabine
  • Humans
  • Lymphoma, B-Cell*
  • Neoplasm Recurrence, Local
  • Oxaliplatin*
  • Retrospective Studies
  • Rituximab

Substances

  • Oxaliplatin
  • Deoxycytidine
  • Rituximab
  • Gemcitabine